Forte Biosciences (FBRX) Non Operating Income (2016 - 2018)
Forte Biosciences' (FBRX) quarterly Non Operating Income came in at -$762000.0 in Q2 2018, down 84.06% year-on-year from -$4.8 million in Q2 2017, and down 2141.18% on a QoQ basis from -$34000.0 in Q1 2018.
Forte Biosciences (FBRX) Non Operating Income (2016 - 2018) Analysis & Trends
Forte Biosciences (FBRX) has 3 years of Non Operating Income data on file, last reported at -$762000.0 in Q2 2018.
- On a quarterly basis, Non Operating Income fell 84.06% year-over-year to -$762000.0 in Q2 2018; TTM through Jun 2018 was -$1.2 million, a 37.49% increase from a year earlier, with the FY2025 full-year figure at $2.3 million, up 106.32% from the prior year.
- Non Operating Income for Q2 2018 stood at -$762000.0, down from -$34000.0 in the prior quarter.
- Over the last five years, Non Operating Income for FBRX reached as high as -$34000.0 in Q1 2018 and fell as low as -$762000.0 in Q2 2018.
- Historically, Non Operating Income has averaged -$388300.0 across 3 years, with a median of -$431000.0 in 2016.
- On a YoY basis, Non Operating Income climbed as much as 93.46% in 2018 and fell as far as 84.06% in 2018.
- Year by year, Non Operating Income stood at -$456000.0 in 2016, then jumped by 67.11% to -$150000.0 in 2017, then tumbled by 408.0% to -$762000.0 in 2018.
- Per Business Quant data, the three most recent Non Operating Income figures were -$762000.0 in Q2 2018, -$34000.0 in Q1 2018, and -$150000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -762,000.00 |
| Mar 31, 2018 | -34,000.00 |
| Dec 31, 2017 | -150,000.00 |
| Sep 30, 2017 | -216,000.00 |
| Jun 30, 2017 | -414,000.00 |
| Mar 31, 2017 | -520,000.00 |
| Dec 31, 2016 | -456,000.00 |
| Sep 30, 2016 | -469,000.00 |
| Jun 30, 2016 | -422,000.00 |
| Mar 31, 2016 | -440,000.00 |